Ethnic traditional medicines focus on efficacy.

As modern medicine faces numerous challenges—such as managing chronic diseases and diagnosing and treating complex, intractable conditions—traditional ethnic medicines are once again coming into the spotlight thanks to their unique clinical value. This resurgence is not merely a simple revival of tradition; rather, it represents a rational choice made by the healthcare system, driven by the growing demand for effective treatments. From the explicit commitment in the “14th Five-Year Plan for TCM Development” to intensify research on the prevention and treatment of major diseases and key conditions where ethnic medicines excel, to the release just months ago of the World Health Organization’s “Traditional Medicine Strategy 2025–2034,” aimed at enhancing global health coverage—these and many other initiatives are accelerating the realization of the full potential of ethnic medicines.

“The core concern of ethnic medicine enterprises is patient benefit; the efficacy of their products is truly the key,” as Mr. Liu Kai lie, Chairman of Qizheng Tibetan Medicine, aptly put it. Efficacy is the very foundation upon which ethnic medicine enterprises can endure. The therapeutic value of ethnic medicine has been clinically validated over thousands of years. In contemporary times, guided by theories of traditional ethnic medicine and employing modern medical research methods such as evidence-based medicine, we are breaking down cognitive barriers between traditional and modern medicine, thereby achieving a more comprehensive understanding and application of these time-honored practices.

The release of therapeutic efficacy hinges on the support of the entire industry chain. From quality control at the source—ensuring the cultivation and supply of medicinal materials—to R&D innovation and green, intelligent manufacturing, as well as academic promotion, channel development, and end-user services, every single link is critical to the product’s therapeutic efficacy. Only through coordinated efforts across all these links can we deliver the highest therapeutic value.
As a leading enterprise in ethnic medicine, Qizheng Tibetan Medicine has consistently placed “patient benefit” at the heart of its mission since its establishment in 1995. Guided by clinical needs, the company continuously optimizes the efficacy and safety of its pharmaceutical products through research and development as well as technological innovation, thereby enhancing the overall patient experience. Thanks to its proven efficacy and high-quality standards, its flagship product—pain-relieving plaster—has long been deeply ingrained in the minds of consumers in the core area of musculoskeletal pain relief. Other products such as Qingpeng Ointment, Bai Mai Ointment, Tiebang Chui Pain Relief Plaster, and Ruyi Zhenbao Tablets have also earned widespread recognition. In the respiratory field, the Shiwei Longdan Flower Granules/Capsules enjoy an excellent reputation; in the gynecological field, Honghua Ruyi Pills are highly acclaimed; in pediatrics, Jiuwei Zhuhuang Powder and Xiao’er Chaiqin Qingjie Granules are widely trusted; and in the digestive field, Renqing Mangjue Capsules, developed with great care, have established a stellar reputation and enjoy strong consumer confidence.

For the past three decades, Qizheng Tibetan Medicine has been deeply rooted in the Tibetan medicine sector, building a comprehensive, integrated industrial ecosystem that spans from medicinal herb cultivation and R&D to intelligent manufacturing, marketing, sales, and healthcare services. Upholding the principle of sustainable development, the company has firmly established its business foundation.

As Qizheng Tibetan Medicine celebrates its 30th anniversary, it’s worth noting that exactly 16 years ago today was the very day this company rang the opening bell for its IPO on the Shenzhen Stock Exchange. Looking ahead, Mr. Liu Kailie stated: “We will foster new forms of productive forces in Tibetan medicine, drive high-quality development, and strive to double our performance within five years, reach 10 billion yuan in revenue within ten years, and become a globally influential Tibetan medicine and health industry group within thirty years—ultimately establishing ourselves as a world-class, sustainably developed enterprise spanning the entire Tibetan medicine value chain.”

Against the backdrop of continued strong support from national policies, this development plan—centered on efficacy—is a vivid testament to the high-quality development of traditional ethnic medicine.

Reporting Media: Shanghai Securities Journal · China Securities Net

Report link: https://www.cnstock.com/commonDetail/504438